Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis

Dae Hyun Kim, Hee Joon Bae, Moon Ku Han, Beom Joon Kim, Sang Soon Park, Tai Hwan Park, Kyung Bok Lee, Kyusik Kang, Jong Moo Park, Youngchai Ko, Soo Joo Lee, Jay Chol Choi, Joon Tae Kim, Ki Hyun Cho, Keun Sik Hong, Yong Jin Cho, Dong Eog Kim, Jun Lee, Juneyoung Lee, Mi Sun OhKyung Ho Yu, Byung Chul Lee, Hyun Wook Nah, Jae Kwan Cha

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We aimed to examine whether direct access to hospitals offering intravenous thrombolysis is associated with functional outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis. We enrolled patients who received intravenous thrombolysis within 4.5 hours of symptom onset using a prospective multicenter registry database. Patients referred directly from the field to organized stroke centers were compared with those who were transferred from non-thrombolysis-capable hospitals in terms of clinical outcomes at 90 days after intravenous recombinant tissue plasminogen activator treatment. We also investigated onset-to-door time and onset-to-needle time according to admission mode. A total of 820 patients (mean age of 67.3 years and median National Institutes of Health Stroke Scale score of 9) were enrolled. Seventeen percent of patients with AIS who received intravenous thrombolytic therapy at 12 hospitals (n = 142) were transferred from other hospitals. The direct admission group had a shorter median onset-to-admission time (63 versus 121 minutes, P < 0.001) and onset-to-needle time (110 versus 161 minutes, P < 0.001) as compared with the indirect admission group. Direct admission was associated with a good outcome with an odds ratio of 1.57 (95% confidence interval: 1.02-2.39, P = 0.036) after adjustment for baseline variables. Direct admission to a hospital with intravenous thrombolysis facilities available at all times was associated with shorter onset-to-needle time and better outcome in patients with AIS undergoing thrombolytic therapy. Our findings support the implementation of regional stroke care programs transporting patients directly to stroke centers to promote faster treatment and to achieve better outcomes.

Original languageEnglish
Pages (from-to)74-79
Number of pages6
JournalJournal of Clinical Neuroscience
Volume27
DOIs
Publication statusPublished - 2016 May 1

Fingerprint

Stroke
Needles
Thrombolytic Therapy
Therapeutics
National Institutes of Health (U.S.)
Tissue Plasminogen Activator
Registries
Odds Ratio
Databases
Confidence Intervals

Keywords

  • Acute ischemic stroke
  • Admission route
  • Interhospital transfer
  • Intravenous thrombolysis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis. / Kim, Dae Hyun; Bae, Hee Joon; Han, Moon Ku; Kim, Beom Joon; Park, Sang Soon; Park, Tai Hwan; Lee, Kyung Bok; Kang, Kyusik; Park, Jong Moo; Ko, Youngchai; Lee, Soo Joo; Choi, Jay Chol; Kim, Joon Tae; Cho, Ki Hyun; Hong, Keun Sik; Cho, Yong Jin; Kim, Dong Eog; Lee, Jun; Lee, Juneyoung; Oh, Mi Sun; Yu, Kyung Ho; Lee, Byung Chul; Nah, Hyun Wook; Cha, Jae Kwan.

In: Journal of Clinical Neuroscience, Vol. 27, 01.05.2016, p. 74-79.

Research output: Contribution to journalArticle

Kim, DH, Bae, HJ, Han, MK, Kim, BJ, Park, SS, Park, TH, Lee, KB, Kang, K, Park, JM, Ko, Y, Lee, SJ, Choi, JC, Kim, JT, Cho, KH, Hong, KS, Cho, YJ, Kim, DE, Lee, J, Lee, J, Oh, MS, Yu, KH, Lee, BC, Nah, HW & Cha, JK 2016, 'Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis', Journal of Clinical Neuroscience, vol. 27, pp. 74-79. https://doi.org/10.1016/j.jocn.2015.06.038
Kim, Dae Hyun ; Bae, Hee Joon ; Han, Moon Ku ; Kim, Beom Joon ; Park, Sang Soon ; Park, Tai Hwan ; Lee, Kyung Bok ; Kang, Kyusik ; Park, Jong Moo ; Ko, Youngchai ; Lee, Soo Joo ; Choi, Jay Chol ; Kim, Joon Tae ; Cho, Ki Hyun ; Hong, Keun Sik ; Cho, Yong Jin ; Kim, Dong Eog ; Lee, Jun ; Lee, Juneyoung ; Oh, Mi Sun ; Yu, Kyung Ho ; Lee, Byung Chul ; Nah, Hyun Wook ; Cha, Jae Kwan. / Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis. In: Journal of Clinical Neuroscience. 2016 ; Vol. 27. pp. 74-79.
@article{0d301b45196942d1aba1832663129385,
title = "Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis",
abstract = "We aimed to examine whether direct access to hospitals offering intravenous thrombolysis is associated with functional outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis. We enrolled patients who received intravenous thrombolysis within 4.5 hours of symptom onset using a prospective multicenter registry database. Patients referred directly from the field to organized stroke centers were compared with those who were transferred from non-thrombolysis-capable hospitals in terms of clinical outcomes at 90 days after intravenous recombinant tissue plasminogen activator treatment. We also investigated onset-to-door time and onset-to-needle time according to admission mode. A total of 820 patients (mean age of 67.3 years and median National Institutes of Health Stroke Scale score of 9) were enrolled. Seventeen percent of patients with AIS who received intravenous thrombolytic therapy at 12 hospitals (n = 142) were transferred from other hospitals. The direct admission group had a shorter median onset-to-admission time (63 versus 121 minutes, P < 0.001) and onset-to-needle time (110 versus 161 minutes, P < 0.001) as compared with the indirect admission group. Direct admission was associated with a good outcome with an odds ratio of 1.57 (95{\%} confidence interval: 1.02-2.39, P = 0.036) after adjustment for baseline variables. Direct admission to a hospital with intravenous thrombolysis facilities available at all times was associated with shorter onset-to-needle time and better outcome in patients with AIS undergoing thrombolytic therapy. Our findings support the implementation of regional stroke care programs transporting patients directly to stroke centers to promote faster treatment and to achieve better outcomes.",
keywords = "Acute ischemic stroke, Admission route, Interhospital transfer, Intravenous thrombolysis",
author = "Kim, {Dae Hyun} and Bae, {Hee Joon} and Han, {Moon Ku} and Kim, {Beom Joon} and Park, {Sang Soon} and Park, {Tai Hwan} and Lee, {Kyung Bok} and Kyusik Kang and Park, {Jong Moo} and Youngchai Ko and Lee, {Soo Joo} and Choi, {Jay Chol} and Kim, {Joon Tae} and Cho, {Ki Hyun} and Hong, {Keun Sik} and Cho, {Yong Jin} and Kim, {Dong Eog} and Jun Lee and Juneyoung Lee and Oh, {Mi Sun} and Yu, {Kyung Ho} and Lee, {Byung Chul} and Nah, {Hyun Wook} and Cha, {Jae Kwan}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.jocn.2015.06.038",
language = "English",
volume = "27",
pages = "74--79",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis

AU - Kim, Dae Hyun

AU - Bae, Hee Joon

AU - Han, Moon Ku

AU - Kim, Beom Joon

AU - Park, Sang Soon

AU - Park, Tai Hwan

AU - Lee, Kyung Bok

AU - Kang, Kyusik

AU - Park, Jong Moo

AU - Ko, Youngchai

AU - Lee, Soo Joo

AU - Choi, Jay Chol

AU - Kim, Joon Tae

AU - Cho, Ki Hyun

AU - Hong, Keun Sik

AU - Cho, Yong Jin

AU - Kim, Dong Eog

AU - Lee, Jun

AU - Lee, Juneyoung

AU - Oh, Mi Sun

AU - Yu, Kyung Ho

AU - Lee, Byung Chul

AU - Nah, Hyun Wook

AU - Cha, Jae Kwan

PY - 2016/5/1

Y1 - 2016/5/1

N2 - We aimed to examine whether direct access to hospitals offering intravenous thrombolysis is associated with functional outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis. We enrolled patients who received intravenous thrombolysis within 4.5 hours of symptom onset using a prospective multicenter registry database. Patients referred directly from the field to organized stroke centers were compared with those who were transferred from non-thrombolysis-capable hospitals in terms of clinical outcomes at 90 days after intravenous recombinant tissue plasminogen activator treatment. We also investigated onset-to-door time and onset-to-needle time according to admission mode. A total of 820 patients (mean age of 67.3 years and median National Institutes of Health Stroke Scale score of 9) were enrolled. Seventeen percent of patients with AIS who received intravenous thrombolytic therapy at 12 hospitals (n = 142) were transferred from other hospitals. The direct admission group had a shorter median onset-to-admission time (63 versus 121 minutes, P < 0.001) and onset-to-needle time (110 versus 161 minutes, P < 0.001) as compared with the indirect admission group. Direct admission was associated with a good outcome with an odds ratio of 1.57 (95% confidence interval: 1.02-2.39, P = 0.036) after adjustment for baseline variables. Direct admission to a hospital with intravenous thrombolysis facilities available at all times was associated with shorter onset-to-needle time and better outcome in patients with AIS undergoing thrombolytic therapy. Our findings support the implementation of regional stroke care programs transporting patients directly to stroke centers to promote faster treatment and to achieve better outcomes.

AB - We aimed to examine whether direct access to hospitals offering intravenous thrombolysis is associated with functional outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis. We enrolled patients who received intravenous thrombolysis within 4.5 hours of symptom onset using a prospective multicenter registry database. Patients referred directly from the field to organized stroke centers were compared with those who were transferred from non-thrombolysis-capable hospitals in terms of clinical outcomes at 90 days after intravenous recombinant tissue plasminogen activator treatment. We also investigated onset-to-door time and onset-to-needle time according to admission mode. A total of 820 patients (mean age of 67.3 years and median National Institutes of Health Stroke Scale score of 9) were enrolled. Seventeen percent of patients with AIS who received intravenous thrombolytic therapy at 12 hospitals (n = 142) were transferred from other hospitals. The direct admission group had a shorter median onset-to-admission time (63 versus 121 minutes, P < 0.001) and onset-to-needle time (110 versus 161 minutes, P < 0.001) as compared with the indirect admission group. Direct admission was associated with a good outcome with an odds ratio of 1.57 (95% confidence interval: 1.02-2.39, P = 0.036) after adjustment for baseline variables. Direct admission to a hospital with intravenous thrombolysis facilities available at all times was associated with shorter onset-to-needle time and better outcome in patients with AIS undergoing thrombolytic therapy. Our findings support the implementation of regional stroke care programs transporting patients directly to stroke centers to promote faster treatment and to achieve better outcomes.

KW - Acute ischemic stroke

KW - Admission route

KW - Interhospital transfer

KW - Intravenous thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=84953438919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953438919&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2015.06.038

DO - 10.1016/j.jocn.2015.06.038

M3 - Article

C2 - 26778045

AN - SCOPUS:84953438919

VL - 27

SP - 74

EP - 79

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -